Latest return on equity
Oramed Pharmaceuticals Return on equity
Direct answer
Oramed Pharmaceuticals's return on equity is 74.24%.
The verified market snapshot reports 74.24%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 11, 2026.
Get free Oramed Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- 74.24%
Explore related company data
View Oramed Pharmaceuticals's market capitalizationView Oramed Pharmaceuticals's p/e ratioView Oramed Pharmaceuticals's price-to-book ratioView Oramed Pharmaceuticals's dividend yieldView Oramed Pharmaceuticals's 52-week price rangeView Oramed Pharmaceuticals's profit marginView Oramed Pharmaceuticals's debt-to-equity ratioView all Oramed Pharmaceuticals key metricsReturn to Oramed Pharmaceuticals profile